Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Ex parte reexam sinks motion to stay in Eastern District of Texas Feb 2009

Ex parte reexam sinks motion to stay in Eastern District of Texas Feb 2009

posted on Nov 19, 2009 11:21AM

I suggest reading the entire article

http://271patent.blogspot.com/2009/02/no-risk-for-me-ex-parte-reexamination.html

Affinity Labs of Texas, LLC v. Dice Electronics, LLC, 9-08-cv-00163 (TXED February 20, 2009, Order).

Judge Clark, ruling on the motion, had this to say:

The parties exchanged Initial Mandatory Disclosures on January 21, 2009. Affinity Labs disclosed its asserted claims, Infringement Contentions, and associated documents on February 2, 2009, and Defendants are required to disclose their Invalidity Contentions and associated documents by March 20, 2009. As discussed in more detail below, much of the discovery essential to the case has already occurred.

In denying the parties’ previous request to extend these deadlines, the court noted that despite requesting and receiving several extensions of their time to answer, “Defendants are again seeking to delay the proceedings by six weeks.” Doc. # 43 at p. 1. The theme of delay is also present in the request for ex parte reexamination, which was not made until more than two months after Affinity Labs filed suit.

The filing of a request for ex parte reexamination by only one of the twenty-four Defendants in these three cases raises a strong inference of gamesmanship. Congress’s intent when it established the inter partes reexamination procedure as part of the American Inventors Protection Act of 1999 was to “‘make reexamination a viable, less-costly alternative to patent litigation by giving third-party requesters the option of inter-partes reexamination procedures’ in which they are ‘afforded an expanded, although still limited, role in the reexamination process.’” Cooper Techs. Co. v. Dudas, 536 F.3d 1330, 1332 (Fed. Cir. 2008) (quoting Senator Orrin Hatch, 145 Cong. Rec. S13259 (Oct. 27, 1999)). No Defendant in this case has taken advantage of Congress’s hard work in offering this option. Rather, one Defendant has reached back in history to the non-binding “no risk for me” ex parte reexamination process, allowing all Defendant to lay behind the log, hoping for favorable developments with the passage of time. Instead of streamlining the process, Defendants’ choice guarantees the imposition of additional costs on Affinity Labs, and indicates a lack of desire to resolve the issues in the case in a timely manner.

* * *

It would be naive to believe that counsel for at least some of the Defendants are not coordinating mutually beneficial defense strategies. No Defendant has been confident enough to ask the PTO for a binding inter partes reexamination. All are waiting to let [reexamination counsel], on behalf of Defendant Dice Electronics, LLC, take a shot at defeating Affinity Labs. Of course, if things do not go well at the PTO, each Defendant in turn can file a request for ex parte reexamination. Defendants could then still assert the same and similar claims in this court. This is underscored by the fact that, when asked whether they were willing to be bound by the result if Affinity Labs succeeds in the ex parte reexamination, Defendants made it clear that they were not.

Share
New Message
Please login to post a reply